These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39082387)

  • 1. Prognostic value of C-reactive protein in patients with glioma: a meta-analysis.
    Jin Y; Ye X
    Biomark Med; 2024; 18(13-14):629-637. PubMed ID: 39082387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta-analysis.
    Feng Y; Wang J; Tan D; Cheng P; Wu A
    Cancer Med; 2019 Dec; 8(17):7454-7468. PubMed ID: 31599129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis.
    Yu X; Zhang X
    Biomark Med; 2024; 18(6):279-289. PubMed ID: 38639733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
    Strojnik T; Smigoc T; Lah TT
    Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of survivin in patients with glioma.
    Zhang S; Zhang C; Song Y; Zhang J; Xu J
    Medicine (Baltimore); 2018 Apr; 97(17):e0571. PubMed ID: 29703049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
    Lu VM; Alvi MA; McDonald KL; Daniels DJ
    J Neurosurg Pediatr; 2019 Mar; 23(3):308-316. PubMed ID: 30544362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microRNA-210 and the prognosis in glioma patients: a meta-analysis.
    Hu X; Yan P; Feng J; Zhang F
    Biomark Med; 2020 Jun; 14(9):795-805. PubMed ID: 32715738
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
    Wang DP; Kang K; Lin Q; Hai J
    Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
    Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
    Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of CRP in glioblastoma?
    Förnvik K; Maddahi A; Liljedahl E; Osther K; Salford LG; Redebrandt HN
    Cancer Treat Res Commun; 2021; 26():100293. PubMed ID: 33385735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of microvessel density in patients with glioma.
    Fan C; Zhang J; Liu Z; He M; Kang T; Du T; Song Y; Fan Y; Xu J
    Medicine (Baltimore); 2019 Mar; 98(9):e14695. PubMed ID: 30817605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 and the survival in glioma: a meta-analysis.
    Wu G; Song X; Liu J; Li S; Gao W; Qiu M; Yang C; Ma Y; Chen Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
    Wang Y; Xu C; Zhang Z
    BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between prediagnostic blood glucose levels, diabetes, and glioma.
    Schwartzbaum J; Edlinger M; Zigmont V; Stattin P; Rempala GA; Nagel G; Hammar N; Ulmer H; Föger B; Walldius G; Manjer J; Malmström H; Feychting M
    Sci Rep; 2017 May; 7(1):1436. PubMed ID: 28469238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
    Wang X; Liu S; Zhao X; Fang E; Zhao X
    PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.